European Union - English - EMA (European Medicines Agency)

covis pharma europe b.v. - aclidinium bromide - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - bretaris genuair is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

European Union - English - EMA (European Medicines Agency)

covis pharma europe b.v. - aclidinium bromide - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - eklira genuair is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

titan ag pty ltd - bifenthrin - granular formulation - bifenthrin pyrethroid active 2.0 g/kg - insecticide

Australia - English - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - aclidinium bromide, quantity: 0.4 mg - inhalation, powder for - excipient ingredients: lactose monohydrate - bretaris genuair is indicated as a long-term maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - cyproterone acetate, quantity: 50 mg - tablet, uncoated - excipient ingredients: povidone; maize starch; lactose monohydrate; colloidal anhydrous silica; magnesium stearate - women:moderately severe to severe signs of androgenization. moderately severe/severe forms of hirsutism. moderately severe/severe androgen-dependent loss of scalp hair (moderately severe/severe androgenic alopecia).moderately severe/severe forms of acne and/or seborrhoea associated with other features of androgenization.cyproterone acetate inhibits the influence of male sex hormones which are also produced by the female. it is thus possible to treat diseases in women caused either by increased production of androgens or a particular sensitivity to these hormones hirsutism and alopecia may be expected to recur over a period of time after cessation of treatment.if cyprostat 50mg is taken during pregnancy, the properties of the preparation may lead to signs of feminisation in the male foetus. therefore, in women of childbearing potential, pregnancy must be excluded at the commencement of treatment and ethinyloestradiol taken as well to ensure contraception. this also promotes regular menstruation men:reduction o

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - mesterolone, quantity: 25 mg - tablet, uncoated - excipient ingredients: propyl hydroxybenzoate; lactose monohydrate; povidone; magnesium stearate; methyl hydroxybenzoate; maize starch - hypogonadism - androgen replacement for male hypogonadism, where there is androgen deficiency confirmed by clinical and biochemical testing (see 'precautions' and 'dosage and administration').

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (germany) - dapoxetine - oral tablet - 60mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a. menarini farmaceutica internazionale srl - dapoxetine - oral tablet - 60mg

European Union - English - EMA (European Medicines Agency)

astrazeneca ab - glycopyrronium, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive - formoterol and glycopyrronium bromide - bevespi aerosphere is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

axichem pty ltd - prosulfocarb - emulsifiable concentrate - prosulfocarb carbamate-thiocarbamate active 800.0 g/l - herbicide